Articles for author: Russ Cohen

Russ Cohen

Most Popular

Insights into Celestica (CLS) Portfolio Expansion Celestica Dives Deep: A Study of Expansion

Celestica Inc. CLS recently unveiled SC6100, a cutting-edge, 2U rackmount all-flash storage controller aiming to elevate performance for enterprise application workloads. Flanked by two EPYC Embedded 9004 series processors from Advanced Micro Devices, Inc. AMD, this innovation promises enhanced energy efficiency for upcoming networking, security, and storage applications. Leveraging the new “Zen 4” core architecture, ...

Russ Cohen

Most Popular

Insights into Bitcoin Investment: Top 5 Stocks Overview Insights into Bitcoin Investment: Top 5 Stocks Overview

The rollercoaster ride of the cryptocurrency market in the first week of August left many investors reeling. Bitcoin, the flagbearer of virtual currencies, soared to an all-time pinnacle of $73,750 on March 14. Nonetheless, the recent market upheaval precipitated a downturn for cryptocurrencies, with Bitcoin plummeting below $55,000. The year started with a bang for ...

Russ Cohen

Most Popular

Insights on Flows into QQQ, AAPL, MSFT, NVDA ETF

Overview of Market Activity Amidst the dynamic ebb and flow of financial markets, a recent revelation of significant capital influx has caught the attention of keen investors. This surge of approximately $1.2 billion dollars into the Invesco QQQ exchange-traded fund (ETF) has stirred discourse among financial analysts and market observers alike. Key Developments in ETF ...

Russ Cohen

Most Popular

Analysis: ETF Outflow Alert for XLC, CHTR, EA, NFLX Decoding ETF Behavior: XLC, CHTR, EA, and NFLX in the Spotlight

Dissecting the Outflow Trends Amidst the hustle and bustle of the stock market, a notable event unfurled last week within the dynamic realm of Exchange Traded Funds (ETFs). Specifically, the Communication Services Select Sector SPDR Fund (XLC) captured the attention with an eye-popping $545.3 million outflow – a substantial 3.0% decline from 215,950,000 to 209,550,000 ...

Russ Cohen

Most Popular

Fostering Growth: Vivani Medical’s Strategic Advancements and Financial Standing

Advancements in Clinical Programs Vivani Medical, Inc., a pioneer in biopharmaceuticals specializing in long-acting drug implants, announced significant strides in their clinical programs to combat obesity and chronic weight management. With a promising start in the fourth quarter of 2024, Vivani is set to begin the NPM-115 clinical program, initiating a first-in-human study concentrating on ...

Russ Cohen

Most Popular

Should You Invest in Leidos (LDOS) Based on Financial Analysis? Is Leidos (LDOS) a Good Investment Choice Amid Wall Street’s Optimism?

When it comes to making investment decisions, many investors turn to analyst recommendations for guidance. The buzz surrounding rating changes by these sell-side analysts can sway a stock’s valuation, but how much weight should you give these opinions? Let’s delve into what industry experts are saying about Leidos (LDOS) as we unpack the significance of ...